nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—CYP2C19—coronary artery disease	0.114	0.643	CbGaD
Norethindrone—ALB—coronary artery disease	0.0633	0.357	CbGaD
Norethindrone—Drospirenone—Eplerenone—coronary artery disease	0.0562	0.199	CrCrCtD
Norethindrone—Cortisone acetate—Eplerenone—coronary artery disease	0.0381	0.135	CrCrCtD
Norethindrone—Fluoxymesterone—Eplerenone—coronary artery disease	0.034	0.12	CrCrCtD
Norethindrone—Progesterone—Eplerenone—coronary artery disease	0.0331	0.117	CrCrCtD
Norethindrone—Testosterone Propionate—Eplerenone—coronary artery disease	0.0331	0.117	CrCrCtD
Norethindrone—Methyltestosterone—Eplerenone—coronary artery disease	0.0323	0.114	CrCrCtD
Norethindrone—Testosterone—Eplerenone—coronary artery disease	0.0287	0.102	CrCrCtD
Norethindrone—Hydrocortisone—Eplerenone—coronary artery disease	0.027	0.0955	CrCrCtD
Norethindrone—CYP3A7—Eplerenone—coronary artery disease	0.0135	0.0341	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0135	0.0341	CbGbCtD
Norethindrone—ALB—Pitavastatin—coronary artery disease	0.0118	0.0299	CbGbCtD
Norethindrone—ALB—Valsartan—coronary artery disease	0.0115	0.0291	CbGbCtD
Norethindrone—ABCB1—Ticagrelor—coronary artery disease	0.0115	0.029	CbGbCtD
Norethindrone—CYP3A5—Clopidogrel—coronary artery disease	0.0109	0.0275	CbGbCtD
Norethindrone—CYP2C19—Gemfibrozil—coronary artery disease	0.0101	0.0256	CbGbCtD
Norethindrone—CYP3A5—Eplerenone—coronary artery disease	0.0101	0.0256	CbGbCtD
Norethindrone—CYP2C19—Clopidogrel—coronary artery disease	0.00878	0.0222	CbGbCtD
Norethindrone—ALB—Rosuvastatin—coronary artery disease	0.00873	0.022	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.0087	0.022	CbGbCtD
Norethindrone—CYP3A7—Simvastatin—coronary artery disease	0.0087	0.022	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00851	0.0215	CbGbCtD
Norethindrone—CYP3A7—Lovastatin—coronary artery disease	0.00851	0.0215	CbGbCtD
Norethindrone—ALB—Acetylsalicylic acid—coronary artery disease	0.00851	0.0215	CbGbCtD
Norethindrone—ALB—Captopril—coronary artery disease	0.0084	0.0212	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00775	0.0196	CbGbCtD
Norethindrone—CYP3A7—Atorvastatin—coronary artery disease	0.00775	0.0196	CbGbCtD
Norethindrone—CYP2C19—Telmisartan—coronary artery disease	0.00768	0.0194	CbGbCtD
Norethindrone—ABCB1—Clopidogrel—coronary artery disease	0.00709	0.0179	CbGbCtD
Norethindrone—ABCB1—Perindopril—coronary artery disease	0.00709	0.0179	CbGbCtD
Norethindrone—CYP3A5—Rosuvastatin—coronary artery disease	0.00702	0.0177	CbGbCtD
Norethindrone—CYP3A4—Ticagrelor—coronary artery disease	0.00687	0.0174	CbGbCtD
Norethindrone—ALB—Furosemide—coronary artery disease	0.00675	0.0171	CbGbCtD
Norethindrone—ALB—Losartan—coronary artery disease	0.00662	0.0167	CbGbCtD
Norethindrone—CYP3A5—Simvastatin—coronary artery disease	0.00652	0.0165	CbGbCtD
Norethindrone—CYP3A5—Lovastatin—coronary artery disease	0.00638	0.0161	CbGbCtD
Norethindrone—CYP3A5—Pravastatin—coronary artery disease	0.00638	0.0161	CbGbCtD
Norethindrone—ABCB1—Pitavastatin—coronary artery disease	0.00619	0.0156	CbGbCtD
Norethindrone—ABCB1—Telmisartan—coronary artery disease	0.00619	0.0156	CbGbCtD
Norethindrone—CYP2C19—Timolol—coronary artery disease	0.00619	0.0156	CbGbCtD
Norethindrone—CYP3A4—Fenofibrate—coronary artery disease	0.00613	0.0155	CbGbCtD
Norethindrone—ABCB1—Enalapril—coronary artery disease	0.00587	0.0148	CbGbCtD
Norethindrone—ABCB1—Lisinopril—coronary artery disease	0.00587	0.0148	CbGbCtD
Norethindrone—CYP3A5—Atorvastatin—coronary artery disease	0.00581	0.0147	CbGbCtD
Norethindrone—CYP2C19—Rosuvastatin—coronary artery disease	0.00566	0.0143	CbGbCtD
Norethindrone—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00552	0.0139	CbGbCtD
Norethindrone—CYP3A5—Losartan—coronary artery disease	0.00532	0.0134	CbGbCtD
Norethindrone—CYP2C19—Simvastatin—coronary artery disease	0.00526	0.0133	CbGbCtD
Norethindrone—CYP2C19—Lovastatin—coronary artery disease	0.00515	0.013	CbGbCtD
Norethindrone—ABCB1—Timolol—coronary artery disease	0.00499	0.0126	CbGbCtD
Norethindrone—CYP3A4—Gemfibrozil—coronary artery disease	0.0049	0.0124	CbGbCtD
Norethindrone—CYP2C19—Atorvastatin—coronary artery disease	0.00469	0.0118	CbGbCtD
Norethindrone—ABCB1—Ezetimibe—coronary artery disease	0.00457	0.0115	CbGbCtD
Norethindrone—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00445	0.0112	CbGbCtD
Norethindrone—ABCB1—Captopril—coronary artery disease	0.0044	0.0111	CbGbCtD
Norethindrone—CYP2C19—Losartan—coronary artery disease	0.00429	0.0108	CbGbCtD
Norethindrone—CYP3A4—Clopidogrel—coronary artery disease	0.00425	0.0107	CbGbCtD
Norethindrone—ABCB1—Simvastatin—coronary artery disease	0.00425	0.0107	CbGbCtD
Norethindrone—ABCB1—Pravastatin—coronary artery disease	0.00415	0.0105	CbGbCtD
Norethindrone—ABCB1—Lovastatin—coronary artery disease	0.00415	0.0105	CbGbCtD
Norethindrone—CYP3A4—Eplerenone—coronary artery disease	0.00395	0.00997	CbGbCtD
Norethindrone—ABCB1—Atorvastatin—coronary artery disease	0.00378	0.00956	CbGbCtD
Norethindrone—CYP3A4—Enalapril—coronary artery disease	0.00352	0.00888	CbGbCtD
Norethindrone—ABCB1—Losartan—coronary artery disease	0.00346	0.00874	CbGbCtD
Norethindrone—CYP3A4—Rosuvastatin—coronary artery disease	0.00274	0.00691	CbGbCtD
Norethindrone—CYP3A4—Ezetimibe—coronary artery disease	0.00274	0.00691	CbGbCtD
Norethindrone—CYP3A4—Simvastatin—coronary artery disease	0.00254	0.00642	CbGbCtD
Norethindrone—CYP3A4—Pravastatin—coronary artery disease	0.00249	0.00629	CbGbCtD
Norethindrone—CYP3A4—Lovastatin—coronary artery disease	0.00249	0.00629	CbGbCtD
Norethindrone—CYP3A4—Atorvastatin—coronary artery disease	0.00227	0.00573	CbGbCtD
Norethindrone—CYP3A4—Losartan—coronary artery disease	0.00207	0.00524	CbGbCtD
Norethindrone—Drospirenone—NR3C2—coronary artery disease	0.000289	0.113	CrCbGaD
Norethindrone—Hydrocortisone—CYP11B2—coronary artery disease	0.000193	0.0753	CrCbGaD
Norethindrone—Danazol—CCL2—coronary artery disease	0.000191	0.0749	CrCbGaD
Norethindrone—Quinestrol—ESR1—coronary artery disease	0.000188	0.0737	CrCbGaD
Norethindrone—Ethynodiol—ESR1—coronary artery disease	0.000155	0.0607	CrCbGaD
Norethindrone—Allylestrenol—ESR1—coronary artery disease	0.000147	0.0573	CrCbGaD
Norethindrone—Mestranol—ESR1—coronary artery disease	0.000143	0.0559	CrCbGaD
Norethindrone—Desogestrel—ESR1—coronary artery disease	0.000141	0.0552	CrCbGaD
Norethindrone—Norgestimate—ESR1—coronary artery disease	0.000132	0.0516	CrCbGaD
Norethindrone—Etonogestrel—ESR1—coronary artery disease	0.000114	0.0447	CrCbGaD
Norethindrone—Progesterone—NR3C2—coronary artery disease	0.000111	0.0435	CrCbGaD
Norethindrone—Ethinyl Estradiol—ESR2—coronary artery disease	0.000111	0.0432	CrCbGaD
Norethindrone—Levonorgestrel—ESR1—coronary artery disease	8.08e-05	0.0316	CrCbGaD
Norethindrone—Progesterone—SLC22A3—coronary artery disease	7.77e-05	0.0304	CrCbGaD
Norethindrone—Fluoxymesterone—ESR1—coronary artery disease	7.7e-05	0.0301	CrCbGaD
Norethindrone—Danazol—ESR1—coronary artery disease	7.36e-05	0.0288	CrCbGaD
Norethindrone—Testosterone—SLC22A3—coronary artery disease	7.35e-05	0.0287	CrCbGaD
Norethindrone—Gastrointestinal disorder—Telmisartan—coronary artery disease	6.94e-05	0.000693	CcSEcCtD
Norethindrone—Fatigue—Telmisartan—coronary artery disease	6.93e-05	0.000692	CcSEcCtD
Norethindrone—Abdominal pain—Olmesartan—coronary artery disease	6.92e-05	0.000691	CcSEcCtD
Norethindrone—Pruritus—Ezetimibe—coronary artery disease	6.91e-05	0.00069	CcSEcCtD
Norethindrone—Gastrointestinal pain—Pravastatin—coronary artery disease	6.89e-05	0.000688	CcSEcCtD
Norethindrone—Alopecia—Lisinopril—coronary artery disease	6.88e-05	0.000687	CcSEcCtD
Norethindrone—Dyspepsia—Captopril—coronary artery disease	6.88e-05	0.000687	CcSEcCtD
Norethindrone—Hypersensitivity—Simvastatin—coronary artery disease	6.86e-05	0.000685	CcSEcCtD
Norethindrone—Insomnia—Perindopril—coronary artery disease	6.86e-05	0.000685	CcSEcCtD
Norethindrone—Asthenia—Eplerenone—coronary artery disease	6.86e-05	0.000685	CcSEcCtD
Norethindrone—Mental disorder—Lisinopril—coronary artery disease	6.82e-05	0.000681	CcSEcCtD
Norethindrone—Ethinyl Estradiol—ESR1—coronary artery disease	6.81e-05	0.0266	CrCbGaD
Norethindrone—Urticaria—Niacin—coronary artery disease	6.79e-05	0.000679	CcSEcCtD
Norethindrone—Nausea—Acetylsalicylic acid—coronary artery disease	6.78e-05	0.000677	CcSEcCtD
Norethindrone—Pruritus—Eplerenone—coronary artery disease	6.76e-05	0.000676	CcSEcCtD
Norethindrone—Abdominal pain—Niacin—coronary artery disease	6.76e-05	0.000675	CcSEcCtD
Norethindrone—Dizziness—Fenofibrate—coronary artery disease	6.74e-05	0.000674	CcSEcCtD
Norethindrone—Somnolence—Perindopril—coronary artery disease	6.74e-05	0.000674	CcSEcCtD
Norethindrone—Fatigue—Captopril—coronary artery disease	6.73e-05	0.000673	CcSEcCtD
Norethindrone—Urticaria—Pravastatin—coronary artery disease	6.69e-05	0.000668	CcSEcCtD
Norethindrone—Gastrointestinal pain—Trandolapril—coronary artery disease	6.69e-05	0.000668	CcSEcCtD
Norethindrone—Asthenia—Simvastatin—coronary artery disease	6.68e-05	0.000668	CcSEcCtD
Norethindrone—Flatulence—Lisinopril—coronary artery disease	6.68e-05	0.000667	CcSEcCtD
Norethindrone—Dyspepsia—Perindopril—coronary artery disease	6.68e-05	0.000667	CcSEcCtD
Norethindrone—Gastrointestinal pain—Enalapril—coronary artery disease	6.66e-05	0.000665	CcSEcCtD
Norethindrone—Abdominal pain—Pravastatin—coronary artery disease	6.66e-05	0.000665	CcSEcCtD
Norethindrone—Tension—Lisinopril—coronary artery disease	6.65e-05	0.000664	CcSEcCtD
Norethindrone—Dizziness—Clopidogrel—coronary artery disease	6.63e-05	0.000662	CcSEcCtD
Norethindrone—Pruritus—Simvastatin—coronary artery disease	6.59e-05	0.000658	CcSEcCtD
Norethindrone—Dizziness—Lovastatin—coronary artery disease	6.58e-05	0.000658	CcSEcCtD
Norethindrone—Nervousness—Lisinopril—coronary artery disease	6.58e-05	0.000658	CcSEcCtD
Norethindrone—Gastrointestinal pain—Telmisartan—coronary artery disease	6.57e-05	0.000656	CcSEcCtD
Norethindrone—Somnolence—Furosemide—coronary artery disease	6.55e-05	0.000655	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Perindopril—coronary artery disease	6.55e-05	0.000654	CcSEcCtD
Norethindrone—Fatigue—Perindopril—coronary artery disease	6.54e-05	0.000653	CcSEcCtD
Norethindrone—Urticaria—Trandolapril—coronary artery disease	6.5e-05	0.000649	CcSEcCtD
Norethindrone—Vomiting—Fenofibrate—coronary artery disease	6.48e-05	0.000648	CcSEcCtD
Norethindrone—Hypersensitivity—Valsartan—coronary artery disease	6.48e-05	0.000647	CcSEcCtD
Norethindrone—Convulsion—Ramipril—coronary artery disease	6.48e-05	0.000647	CcSEcCtD
Norethindrone—Urticaria—Enalapril—coronary artery disease	6.47e-05	0.000646	CcSEcCtD
Norethindrone—Abdominal pain—Trandolapril—coronary artery disease	6.46e-05	0.000646	CcSEcCtD
Norethindrone—Dizziness—Ezetimibe—coronary artery disease	6.46e-05	0.000645	CcSEcCtD
Norethindrone—Abdominal pain—Enalapril—coronary artery disease	6.44e-05	0.000643	CcSEcCtD
Norethindrone—Insomnia—Losartan—coronary artery disease	6.43e-05	0.000643	CcSEcCtD
Norethindrone—Rash—Fenofibrate—coronary artery disease	6.43e-05	0.000642	CcSEcCtD
Norethindrone—Dermatitis—Fenofibrate—coronary artery disease	6.42e-05	0.000642	CcSEcCtD
Norethindrone—Headache—Fenofibrate—coronary artery disease	6.39e-05	0.000638	CcSEcCtD
Norethindrone—Gastrointestinal pain—Captopril—coronary artery disease	6.39e-05	0.000638	CcSEcCtD
Norethindrone—Urticaria—Telmisartan—coronary artery disease	6.38e-05	0.000637	CcSEcCtD
Norethindrone—Vomiting—Clopidogrel—coronary artery disease	6.37e-05	0.000637	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Furosemide—coronary artery disease	6.37e-05	0.000636	CcSEcCtD
Norethindrone—Fatigue—Furosemide—coronary artery disease	6.36e-05	0.000635	CcSEcCtD
Norethindrone—Abdominal pain—Telmisartan—coronary artery disease	6.35e-05	0.000634	CcSEcCtD
Norethindrone—Vomiting—Lovastatin—coronary artery disease	6.33e-05	0.000632	CcSEcCtD
Norethindrone—Somnolence—Losartan—coronary artery disease	6.32e-05	0.000632	CcSEcCtD
Norethindrone—Dizziness—Eplerenone—coronary artery disease	6.32e-05	0.000631	CcSEcCtD
Norethindrone—Rash—Clopidogrel—coronary artery disease	6.32e-05	0.000631	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	6.32e-05	0.000631	CcSEcCtD
Norethindrone—Dermatitis—Clopidogrel—coronary artery disease	6.31e-05	0.000631	CcSEcCtD
Norethindrone—Asthenia—Valsartan—coronary artery disease	6.31e-05	0.00063	CcSEcCtD
Norethindrone—Hypersensitivity—Niacin—coronary artery disease	6.3e-05	0.000629	CcSEcCtD
Norethindrone—Asthenia—Olmesartan—coronary artery disease	6.28e-05	0.000627	CcSEcCtD
Norethindrone—Headache—Clopidogrel—coronary artery disease	6.28e-05	0.000627	CcSEcCtD
Norethindrone—Rash—Lovastatin—coronary artery disease	6.28e-05	0.000627	CcSEcCtD
Norethindrone—Dermatitis—Lovastatin—coronary artery disease	6.27e-05	0.000627	CcSEcCtD
Norethindrone—Dyspepsia—Losartan—coronary artery disease	6.26e-05	0.000626	CcSEcCtD
Norethindrone—Headache—Lovastatin—coronary artery disease	6.24e-05	0.000623	CcSEcCtD
Norethindrone—Pruritus—Valsartan—coronary artery disease	6.22e-05	0.000622	CcSEcCtD
Norethindrone—Vomiting—Ezetimibe—coronary artery disease	6.21e-05	0.00062	CcSEcCtD
Norethindrone—Hypersensitivity—Pravastatin—coronary artery disease	6.2e-05	0.00062	CcSEcCtD
Norethindrone—Gastrointestinal pain—Perindopril—coronary artery disease	6.2e-05	0.00062	CcSEcCtD
Norethindrone—Pruritus—Olmesartan—coronary artery disease	6.19e-05	0.000619	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	6.18e-05	0.000617	CcSEcCtD
Norethindrone—Abdominal pain—Captopril—coronary artery disease	6.17e-05	0.000617	CcSEcCtD
Norethindrone—Dizziness—Simvastatin—coronary artery disease	6.16e-05	0.000615	CcSEcCtD
Norethindrone—Rash—Ezetimibe—coronary artery disease	6.16e-05	0.000615	CcSEcCtD
Norethindrone—Dermatitis—Ezetimibe—coronary artery disease	6.15e-05	0.000615	CcSEcCtD
Norethindrone—Asthenia—Niacin—coronary artery disease	6.14e-05	0.000613	CcSEcCtD
Norethindrone—Fatigue—Losartan—coronary artery disease	6.13e-05	0.000613	CcSEcCtD
Norethindrone—Headache—Ezetimibe—coronary artery disease	6.12e-05	0.000611	CcSEcCtD
Norethindrone—Anaphylactic shock—Ramipril—coronary artery disease	6.1e-05	0.000609	CcSEcCtD
Norethindrone—Oedema—Ramipril—coronary artery disease	6.1e-05	0.000609	CcSEcCtD
Norethindrone—Vomiting—Eplerenone—coronary artery disease	6.08e-05	0.000607	CcSEcCtD
Norethindrone—Nausea—Fenofibrate—coronary artery disease	6.06e-05	0.000605	CcSEcCtD
Norethindrone—Pruritus—Niacin—coronary artery disease	6.05e-05	0.000604	CcSEcCtD
Norethindrone—Asthenia—Pravastatin—coronary artery disease	6.04e-05	0.000603	CcSEcCtD
Norethindrone—Gastrointestinal pain—Furosemide—coronary artery disease	6.03e-05	0.000602	CcSEcCtD
Norethindrone—Rash—Eplerenone—coronary artery disease	6.03e-05	0.000602	CcSEcCtD
Norethindrone—Urticaria—Perindopril—coronary artery disease	6.02e-05	0.000602	CcSEcCtD
Norethindrone—Hypersensitivity—Trandolapril—coronary artery disease	6.02e-05	0.000602	CcSEcCtD
Norethindrone—Dermatitis—Eplerenone—coronary artery disease	6.02e-05	0.000602	CcSEcCtD
Norethindrone—Hypersensitivity—Enalapril—coronary artery disease	6e-05	0.000599	CcSEcCtD
Norethindrone—Abdominal pain—Perindopril—coronary artery disease	6e-05	0.000599	CcSEcCtD
Norethindrone—Headache—Eplerenone—coronary artery disease	5.99e-05	0.000598	CcSEcCtD
Norethindrone—Anaphylactic shock—Timolol—coronary artery disease	5.96e-05	0.000596	CcSEcCtD
Norethindrone—Oedema—Timolol—coronary artery disease	5.96e-05	0.000596	CcSEcCtD
Norethindrone—Pruritus—Pravastatin—coronary artery disease	5.96e-05	0.000595	CcSEcCtD
Norethindrone—Nausea—Clopidogrel—coronary artery disease	5.95e-05	0.000595	CcSEcCtD
Norethindrone—Skin disorder—Ramipril—coronary artery disease	5.92e-05	0.000592	CcSEcCtD
Norethindrone—Vomiting—Simvastatin—coronary artery disease	5.92e-05	0.000592	CcSEcCtD
Norethindrone—Hypersensitivity—Telmisartan—coronary artery disease	5.92e-05	0.000591	CcSEcCtD
Norethindrone—Nausea—Lovastatin—coronary artery disease	5.91e-05	0.000591	CcSEcCtD
Norethindrone—Rash—Simvastatin—coronary artery disease	5.87e-05	0.000587	CcSEcCtD
Norethindrone—Dermatitis—Simvastatin—coronary artery disease	5.87e-05	0.000586	CcSEcCtD
Norethindrone—Asthenia—Trandolapril—coronary artery disease	5.87e-05	0.000586	CcSEcCtD
Norethindrone—Urticaria—Furosemide—coronary artery disease	5.86e-05	0.000585	CcSEcCtD
Norethindrone—Asthenia—Enalapril—coronary artery disease	5.84e-05	0.000584	CcSEcCtD
Norethindrone—Headache—Simvastatin—coronary artery disease	5.83e-05	0.000583	CcSEcCtD
Norethindrone—Abdominal pain—Furosemide—coronary artery disease	5.83e-05	0.000582	CcSEcCtD
Norethindrone—Gastrointestinal pain—Losartan—coronary artery disease	5.82e-05	0.000581	CcSEcCtD
Norethindrone—Dizziness—Valsartan—coronary artery disease	5.82e-05	0.000581	CcSEcCtD
Norethindrone—Nausea—Ezetimibe—coronary artery disease	5.8e-05	0.000579	CcSEcCtD
Norethindrone—Skin disorder—Timolol—coronary artery disease	5.79e-05	0.000579	CcSEcCtD
Norethindrone—Dizziness—Olmesartan—coronary artery disease	5.79e-05	0.000578	CcSEcCtD
Norethindrone—Pruritus—Trandolapril—coronary artery disease	5.79e-05	0.000578	CcSEcCtD
Norethindrone—Asthenia—Telmisartan—coronary artery disease	5.76e-05	0.000576	CcSEcCtD
Norethindrone—Pruritus—Enalapril—coronary artery disease	5.76e-05	0.000576	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	5.73e-05	0.000572	CcSEcCtD
Norethindrone—Pruritus—Telmisartan—coronary artery disease	5.68e-05	0.000568	CcSEcCtD
Norethindrone—Nausea—Eplerenone—coronary artery disease	5.68e-05	0.000567	CcSEcCtD
Norethindrone—Dizziness—Niacin—coronary artery disease	5.66e-05	0.000565	CcSEcCtD
Norethindrone—Urticaria—Losartan—coronary artery disease	5.65e-05	0.000565	CcSEcCtD
Norethindrone—Abdominal pain—Losartan—coronary artery disease	5.62e-05	0.000562	CcSEcCtD
Norethindrone—Asthenia—Captopril—coronary artery disease	5.6e-05	0.00056	CcSEcCtD
Norethindrone—Vomiting—Valsartan—coronary artery disease	5.59e-05	0.000559	CcSEcCtD
Norethindrone—Dizziness—Pravastatin—coronary artery disease	5.57e-05	0.000556	CcSEcCtD
Norethindrone—Vomiting—Olmesartan—coronary artery disease	5.57e-05	0.000556	CcSEcCtD
Norethindrone—Rash—Valsartan—coronary artery disease	5.55e-05	0.000554	CcSEcCtD
Norethindrone—Dermatitis—Valsartan—coronary artery disease	5.54e-05	0.000553	CcSEcCtD
Norethindrone—Nausea—Simvastatin—coronary artery disease	5.53e-05	0.000553	CcSEcCtD
Norethindrone—Anaphylactic shock—Lisinopril—coronary artery disease	5.53e-05	0.000553	CcSEcCtD
Norethindrone—Oedema—Lisinopril—coronary artery disease	5.53e-05	0.000553	CcSEcCtD
Norethindrone—Pruritus—Captopril—coronary artery disease	5.53e-05	0.000552	CcSEcCtD
Norethindrone—Rash—Olmesartan—coronary artery disease	5.52e-05	0.000551	CcSEcCtD
Norethindrone—Insomnia—Ramipril—coronary artery disease	5.52e-05	0.000551	CcSEcCtD
Norethindrone—Dermatitis—Olmesartan—coronary artery disease	5.51e-05	0.000551	CcSEcCtD
Norethindrone—Headache—Valsartan—coronary artery disease	5.51e-05	0.00055	CcSEcCtD
Norethindrone—Headache—Olmesartan—coronary artery disease	5.48e-05	0.000548	CcSEcCtD
Norethindrone—Asthenia—Perindopril—coronary artery disease	5.44e-05	0.000544	CcSEcCtD
Norethindrone—Vomiting—Niacin—coronary artery disease	5.44e-05	0.000543	CcSEcCtD
Norethindrone—Hypersensitivity—Furosemide—coronary artery disease	5.43e-05	0.000543	CcSEcCtD
Norethindrone—Somnolence—Ramipril—coronary artery disease	5.42e-05	0.000542	CcSEcCtD
Norethindrone—Dizziness—Trandolapril—coronary artery disease	5.41e-05	0.00054	CcSEcCtD
Norethindrone—Insomnia—Timolol—coronary artery disease	5.39e-05	0.000539	CcSEcCtD
Norethindrone—Rash—Niacin—coronary artery disease	5.39e-05	0.000539	CcSEcCtD
Norethindrone—Dermatitis—Niacin—coronary artery disease	5.39e-05	0.000538	CcSEcCtD
Norethindrone—Dizziness—Enalapril—coronary artery disease	5.39e-05	0.000538	CcSEcCtD
Norethindrone—Skin disorder—Lisinopril—coronary artery disease	5.37e-05	0.000537	CcSEcCtD
Norethindrone—Dyspepsia—Ramipril—coronary artery disease	5.37e-05	0.000536	CcSEcCtD
Norethindrone—Pruritus—Perindopril—coronary artery disease	5.37e-05	0.000536	CcSEcCtD
Norethindrone—Headache—Niacin—coronary artery disease	5.36e-05	0.000535	CcSEcCtD
Norethindrone—Vomiting—Pravastatin—coronary artery disease	5.35e-05	0.000535	CcSEcCtD
Norethindrone—Dizziness—Telmisartan—coronary artery disease	5.31e-05	0.000531	CcSEcCtD
Norethindrone—Rash—Pravastatin—coronary artery disease	5.31e-05	0.00053	CcSEcCtD
Norethindrone—Dermatitis—Pravastatin—coronary artery disease	5.3e-05	0.00053	CcSEcCtD
Norethindrone—Somnolence—Timolol—coronary artery disease	5.3e-05	0.00053	CcSEcCtD
Norethindrone—Asthenia—Furosemide—coronary artery disease	5.29e-05	0.000528	CcSEcCtD
Norethindrone—Headache—Pravastatin—coronary artery disease	5.28e-05	0.000527	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Ramipril—coronary artery disease	5.27e-05	0.000526	CcSEcCtD
Norethindrone—Fatigue—Ramipril—coronary artery disease	5.26e-05	0.000525	CcSEcCtD
Norethindrone—Dyspepsia—Timolol—coronary artery disease	5.25e-05	0.000524	CcSEcCtD
Norethindrone—Hypersensitivity—Losartan—coronary artery disease	5.24e-05	0.000524	CcSEcCtD
Norethindrone—Nausea—Valsartan—coronary artery disease	5.22e-05	0.000522	CcSEcCtD
Norethindrone—Pruritus—Furosemide—coronary artery disease	5.22e-05	0.000521	CcSEcCtD
Norethindrone—Nausea—Olmesartan—coronary artery disease	5.2e-05	0.000519	CcSEcCtD
Norethindrone—Vomiting—Trandolapril—coronary artery disease	5.2e-05	0.000519	CcSEcCtD
Norethindrone—Vomiting—Enalapril—coronary artery disease	5.18e-05	0.000517	CcSEcCtD
Norethindrone—Dizziness—Captopril—coronary artery disease	5.17e-05	0.000516	CcSEcCtD
Norethindrone—Rash—Trandolapril—coronary artery disease	5.16e-05	0.000515	CcSEcCtD
Norethindrone—Dermatitis—Trandolapril—coronary artery disease	5.15e-05	0.000515	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Timolol—coronary artery disease	5.15e-05	0.000514	CcSEcCtD
Norethindrone—Fatigue—Timolol—coronary artery disease	5.14e-05	0.000514	CcSEcCtD
Norethindrone—Rash—Enalapril—coronary artery disease	5.14e-05	0.000513	CcSEcCtD
Norethindrone—Dermatitis—Enalapril—coronary artery disease	5.13e-05	0.000512	CcSEcCtD
Norethindrone—Headache—Trandolapril—coronary artery disease	5.12e-05	0.000512	CcSEcCtD
Norethindrone—Vomiting—Telmisartan—coronary artery disease	5.11e-05	0.00051	CcSEcCtD
Norethindrone—Asthenia—Losartan—coronary artery disease	5.1e-05	0.00051	CcSEcCtD
Norethindrone—Headache—Enalapril—coronary artery disease	5.1e-05	0.00051	CcSEcCtD
Norethindrone—Nausea—Niacin—coronary artery disease	5.08e-05	0.000507	CcSEcCtD
Norethindrone—Rash—Telmisartan—coronary artery disease	5.06e-05	0.000506	CcSEcCtD
Norethindrone—Dermatitis—Telmisartan—coronary artery disease	5.06e-05	0.000505	CcSEcCtD
Norethindrone—Pruritus—Losartan—coronary artery disease	5.03e-05	0.000503	CcSEcCtD
Norethindrone—Headache—Telmisartan—coronary artery disease	5.03e-05	0.000503	CcSEcCtD
Norethindrone—Dizziness—Perindopril—coronary artery disease	5.02e-05	0.000501	CcSEcCtD
Norethindrone—Insomnia—Lisinopril—coronary artery disease	5e-05	0.0005	CcSEcCtD
Norethindrone—Nausea—Pravastatin—coronary artery disease	5e-05	0.0005	CcSEcCtD
Norethindrone—Gastrointestinal pain—Ramipril—coronary artery disease	4.99e-05	0.000498	CcSEcCtD
Norethindrone—Vomiting—Captopril—coronary artery disease	4.97e-05	0.000496	CcSEcCtD
Norethindrone—Drospirenone—PTGS2—coronary artery disease	4.95e-05	0.0193	CrCbGaD
Norethindrone—Rash—Captopril—coronary artery disease	4.93e-05	0.000492	CcSEcCtD
Norethindrone—Dermatitis—Captopril—coronary artery disease	4.92e-05	0.000492	CcSEcCtD
Norethindrone—Somnolence—Lisinopril—coronary artery disease	4.92e-05	0.000491	CcSEcCtD
Norethindrone—Headache—Captopril—coronary artery disease	4.89e-05	0.000489	CcSEcCtD
Norethindrone—Gastrointestinal pain—Timolol—coronary artery disease	4.88e-05	0.000487	CcSEcCtD
Norethindrone—Dizziness—Furosemide—coronary artery disease	4.88e-05	0.000487	CcSEcCtD
Norethindrone—Dyspepsia—Lisinopril—coronary artery disease	4.87e-05	0.000486	CcSEcCtD
Norethindrone—Nausea—Trandolapril—coronary artery disease	4.86e-05	0.000485	CcSEcCtD
Norethindrone—Urticaria—Ramipril—coronary artery disease	4.85e-05	0.000484	CcSEcCtD
Norethindrone—Nausea—Enalapril—coronary artery disease	4.84e-05	0.000483	CcSEcCtD
Norethindrone—Vomiting—Perindopril—coronary artery disease	4.82e-05	0.000482	CcSEcCtD
Norethindrone—Abdominal pain—Ramipril—coronary artery disease	4.82e-05	0.000482	CcSEcCtD
Norethindrone—Rash—Perindopril—coronary artery disease	4.78e-05	0.000478	CcSEcCtD
Norethindrone—Dermatitis—Perindopril—coronary artery disease	4.78e-05	0.000477	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.78e-05	0.000477	CcSEcCtD
Norethindrone—Nausea—Telmisartan—coronary artery disease	4.77e-05	0.000477	CcSEcCtD
Norethindrone—Fatigue—Lisinopril—coronary artery disease	4.77e-05	0.000476	CcSEcCtD
Norethindrone—Headache—Perindopril—coronary artery disease	4.75e-05	0.000475	CcSEcCtD
Norethindrone—Urticaria—Timolol—coronary artery disease	4.74e-05	0.000473	CcSEcCtD
Norethindrone—Abdominal pain—Timolol—coronary artery disease	4.71e-05	0.000471	CcSEcCtD
Norethindrone—Dizziness—Losartan—coronary artery disease	4.7e-05	0.00047	CcSEcCtD
Norethindrone—Vomiting—Furosemide—coronary artery disease	4.69e-05	0.000468	CcSEcCtD
Norethindrone—Rash—Furosemide—coronary artery disease	4.65e-05	0.000464	CcSEcCtD
Norethindrone—Dermatitis—Furosemide—coronary artery disease	4.64e-05	0.000464	CcSEcCtD
Norethindrone—Nausea—Captopril—coronary artery disease	4.64e-05	0.000463	CcSEcCtD
Norethindrone—Headache—Furosemide—coronary artery disease	4.62e-05	0.000461	CcSEcCtD
Norethindrone—Gastrointestinal pain—Lisinopril—coronary artery disease	4.52e-05	0.000452	CcSEcCtD
Norethindrone—Vomiting—Losartan—coronary artery disease	4.52e-05	0.000452	CcSEcCtD
Norethindrone—Nausea—Perindopril—coronary artery disease	4.5e-05	0.00045	CcSEcCtD
Norethindrone—Hypersensitivity—Ramipril—coronary artery disease	4.49e-05	0.000449	CcSEcCtD
Norethindrone—Rash—Losartan—coronary artery disease	4.49e-05	0.000448	CcSEcCtD
Norethindrone—Dermatitis—Losartan—coronary artery disease	4.48e-05	0.000448	CcSEcCtD
Norethindrone—Headache—Losartan—coronary artery disease	4.46e-05	0.000445	CcSEcCtD
Norethindrone—Urticaria—Lisinopril—coronary artery disease	4.39e-05	0.000439	CcSEcCtD
Norethindrone—Hypersensitivity—Timolol—coronary artery disease	4.39e-05	0.000439	CcSEcCtD
Norethindrone—Nausea—Furosemide—coronary artery disease	4.38e-05	0.000437	CcSEcCtD
Norethindrone—Asthenia—Ramipril—coronary artery disease	4.38e-05	0.000437	CcSEcCtD
Norethindrone—Abdominal pain—Lisinopril—coronary artery disease	4.37e-05	0.000437	CcSEcCtD
Norethindrone—Pruritus—Ramipril—coronary artery disease	4.32e-05	0.000431	CcSEcCtD
Norethindrone—Asthenia—Timolol—coronary artery disease	4.28e-05	0.000427	CcSEcCtD
Norethindrone—Nausea—Losartan—coronary artery disease	4.23e-05	0.000422	CcSEcCtD
Norethindrone—Pruritus—Timolol—coronary artery disease	4.22e-05	0.000421	CcSEcCtD
Norethindrone—Hypersensitivity—Lisinopril—coronary artery disease	4.08e-05	0.000407	CcSEcCtD
Norethindrone—Dizziness—Ramipril—coronary artery disease	4.03e-05	0.000403	CcSEcCtD
Norethindrone—Asthenia—Lisinopril—coronary artery disease	3.97e-05	0.000396	CcSEcCtD
Norethindrone—Dizziness—Timolol—coronary artery disease	3.94e-05	0.000394	CcSEcCtD
Norethindrone—Pruritus—Lisinopril—coronary artery disease	3.91e-05	0.000391	CcSEcCtD
Norethindrone—Vomiting—Ramipril—coronary artery disease	3.88e-05	0.000387	CcSEcCtD
Norethindrone—Rash—Ramipril—coronary artery disease	3.85e-05	0.000384	CcSEcCtD
Norethindrone—Dermatitis—Ramipril—coronary artery disease	3.84e-05	0.000384	CcSEcCtD
Norethindrone—Headache—Ramipril—coronary artery disease	3.82e-05	0.000382	CcSEcCtD
Norethindrone—Progesterone—ESR1—coronary artery disease	3.82e-05	0.0149	CrCbGaD
Norethindrone—Vomiting—Timolol—coronary artery disease	3.79e-05	0.000379	CcSEcCtD
Norethindrone—Rash—Timolol—coronary artery disease	3.76e-05	0.000376	CcSEcCtD
Norethindrone—Dermatitis—Timolol—coronary artery disease	3.76e-05	0.000375	CcSEcCtD
Norethindrone—Headache—Timolol—coronary artery disease	3.74e-05	0.000373	CcSEcCtD
Norethindrone—Dizziness—Lisinopril—coronary artery disease	3.66e-05	0.000365	CcSEcCtD
Norethindrone—Nausea—Ramipril—coronary artery disease	3.62e-05	0.000362	CcSEcCtD
Norethindrone—Nausea—Timolol—coronary artery disease	3.54e-05	0.000354	CcSEcCtD
Norethindrone—Vomiting—Lisinopril—coronary artery disease	3.52e-05	0.000351	CcSEcCtD
Norethindrone—Rash—Lisinopril—coronary artery disease	3.49e-05	0.000348	CcSEcCtD
Norethindrone—Dermatitis—Lisinopril—coronary artery disease	3.48e-05	0.000348	CcSEcCtD
Norethindrone—Headache—Lisinopril—coronary artery disease	3.47e-05	0.000346	CcSEcCtD
Norethindrone—Nausea—Lisinopril—coronary artery disease	3.29e-05	0.000328	CcSEcCtD
Norethindrone—Progesterone—CYP2C19—coronary artery disease	3.06e-05	0.012	CrCbGaD
Norethindrone—Testosterone—CYP2C19—coronary artery disease	2.89e-05	0.0113	CrCbGaD
Norethindrone—Methyltestosterone—ALB—coronary artery disease	2.77e-05	0.0108	CrCbGaD
Norethindrone—Testosterone—ALB—coronary artery disease	1.61e-05	0.00628	CrCbGaD
Norethindrone—CYP2C19—Metabolism—ALDH2—coronary artery disease	3.74e-06	9.05e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPP2CA—coronary artery disease	3.74e-06	9.03e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—JAK2—coronary artery disease	3.73e-06	9.02e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—FGF2—coronary artery disease	3.73e-06	9e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NOS3—coronary artery disease	3.67e-06	8.88e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ABCA1—coronary artery disease	3.67e-06	8.87e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PSMB5—coronary artery disease	3.66e-06	8.85e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PSMA6—coronary artery disease	3.66e-06	8.85e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALDH2—coronary artery disease	3.65e-06	8.83e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	3.65e-06	8.82e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HBA1—coronary artery disease	3.65e-06	8.82e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—LIPC—coronary artery disease	3.65e-06	8.82e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3C2A—coronary artery disease	3.65e-06	8.82e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AKR1B1—coronary artery disease	3.64e-06	8.81e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HK2—coronary artery disease	3.64e-06	8.81e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOC3—coronary artery disease	3.63e-06	8.76e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—LDLR—coronary artery disease	3.6e-06	8.71e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.6e-06	8.7e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—MTHFR—coronary artery disease	3.59e-06	8.67e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CTGF—coronary artery disease	3.58e-06	8.65e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—JAK2—coronary artery disease	3.57e-06	8.63e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTT1—coronary artery disease	3.56e-06	8.61e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP2C19—coronary artery disease	3.56e-06	8.61e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—LIPC—coronary artery disease	3.56e-06	8.61e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HBA1—coronary artery disease	3.56e-06	8.61e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3C2A—coronary artery disease	3.56e-06	8.61e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC9A1—coronary artery disease	3.56e-06	8.61e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GOT1—coronary artery disease	3.55e-06	8.59e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GGT1—coronary artery disease	3.55e-06	8.59e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HMGCR—coronary artery disease	3.55e-06	8.57e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GOT2—coronary artery disease	3.55e-06	8.57e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOC3—coronary artery disease	3.54e-06	8.55e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GCLC—coronary artery disease	3.52e-06	8.51e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CETP—coronary artery disease	3.52e-06	8.51e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—LDLR—coronary artery disease	3.52e-06	8.5e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC27A1—coronary artery disease	3.49e-06	8.44e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SDC1—coronary artery disease	3.48e-06	8.41e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTT1—coronary artery disease	3.48e-06	8.4e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC9A1—coronary artery disease	3.48e-06	8.4e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CETP—coronary artery disease	3.43e-06	8.3e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GCLC—coronary artery disease	3.43e-06	8.3e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LCAT—coronary artery disease	3.43e-06	8.28e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CPT1B—coronary artery disease	3.43e-06	8.28e-05	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	3.43e-06	8.28e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AGT—coronary artery disease	3.41e-06	8.24e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SDC1—coronary artery disease	3.4e-06	8.21e-05	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	3.37e-06	8.15e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOA4—coronary artery disease	3.36e-06	8.13e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—APOE—coronary artery disease	3.34e-06	8.07e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—APOA1—coronary artery disease	3.3e-06	7.98e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PSMB5—coronary artery disease	3.29e-06	7.95e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PSMA6—coronary artery disease	3.29e-06	7.95e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.28e-06	7.93e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PLCB1—coronary artery disease	3.26e-06	7.88e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CXCL8—coronary artery disease	3.26e-06	7.88e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.25e-06	7.85e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GCLM—coronary artery disease	3.25e-06	7.85e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CTGF—coronary artery disease	3.21e-06	7.76e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PSMB5—coronary artery disease	3.21e-06	7.76e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PSMA6—coronary artery disease	3.21e-06	7.76e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.2e-06	7.73e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTP1—coronary artery disease	3.19e-06	7.72e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HMGCR—coronary artery disease	3.18e-06	7.69e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GOT2—coronary artery disease	3.18e-06	7.69e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	3.16e-06	7.64e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ABCA1—coronary artery disease	3.16e-06	7.64e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—HMOX1—coronary artery disease	3.15e-06	7.61e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.15e-06	7.6e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.15e-06	7.6e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CTGF—coronary artery disease	3.13e-06	7.58e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CASP3—coronary artery disease	3.12e-06	7.54e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HMGCR—coronary artery disease	3.11e-06	7.51e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GOT2—coronary artery disease	3.11e-06	7.51e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CAT—coronary artery disease	3.11e-06	7.51e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.1e-06	7.49e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GOT1—coronary artery disease	3.06e-06	7.4e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GGT1—coronary artery disease	3.06e-06	7.4e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.05e-06	7.38e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HADH—coronary artery disease	3.05e-06	7.38e-05	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	3.05e-06	7.36e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CCND1—coronary artery disease	3.04e-06	7.34e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOB—coronary artery disease	3.02e-06	7.29e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MMP9—coronary artery disease	2.95e-06	7.12e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTM1—coronary artery disease	2.93e-06	7.09e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PLCB1—coronary artery disease	2.93e-06	7.07e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPARG—coronary artery disease	2.91e-06	7.03e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPX2—coronary artery disease	2.89e-06	7e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.89e-06	7e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOA2—coronary artery disease	2.89e-06	7e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—LPL—coronary artery disease	2.88e-06	6.96e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.87e-06	6.94e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—POMC—coronary artery disease	2.87e-06	6.93e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.86e-06	6.91e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HK1—coronary artery disease	2.86e-06	6.91e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.86e-06	6.91e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPX4—coronary artery disease	2.86e-06	6.91e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PLCB1—coronary artery disease	2.86e-06	6.9e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ABCA1—coronary artery disease	2.84e-06	6.86e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HADHA—coronary artery disease	2.83e-06	6.83e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GPX1—coronary artery disease	2.81e-06	6.79e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.79e-06	6.75e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ABCA1—coronary artery disease	2.77e-06	6.69e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—VEGFA—coronary artery disease	2.77e-06	6.69e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LPA—coronary artery disease	2.76e-06	6.67e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTP1—coronary artery disease	2.75e-06	6.64e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GGT1—coronary artery disease	2.75e-06	6.64e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GOT1—coronary artery disease	2.75e-06	6.64e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CD36—coronary artery disease	2.74e-06	6.61e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARGC1A—coronary artery disease	2.72e-06	6.58e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HMOX1—coronary artery disease	2.71e-06	6.55e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPP2CA—coronary artery disease	2.7e-06	6.53e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GGT1—coronary artery disease	2.68e-06	6.48e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GOT1—coronary artery disease	2.68e-06	6.48e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CAT—coronary artery disease	2.68e-06	6.47e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.67e-06	6.46e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOA5—coronary artery disease	2.65e-06	6.4e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—VEGFA—coronary artery disease	2.65e-06	6.4e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ALB—coronary artery disease	2.61e-06	6.32e-05	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—AKT1—coronary artery disease	2.6e-06	6.28e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOB—coronary artery disease	2.6e-06	6.28e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—P4HB—coronary artery disease	2.6e-06	6.27e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MTHFR—coronary artery disease	2.59e-06	6.27e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.55e-06	6.16e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TGFB1—coronary artery disease	2.54e-06	6.14e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTM1—coronary artery disease	2.53e-06	6.11e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—NOS3—coronary artery disease	2.5e-06	6.05e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—MAPK1—coronary artery disease	2.49e-06	6.02e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—LPL—coronary artery disease	2.48e-06	5.99e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTP1—coronary artery disease	2.47e-06	5.96e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AGT—coronary artery disease	2.46e-06	5.95e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	2.44e-06	5.91e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HMOX1—coronary artery disease	2.43e-06	5.88e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TGFB1—coronary artery disease	2.43e-06	5.87e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GPX1—coronary artery disease	2.42e-06	5.85e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOE—coronary artery disease	2.41e-06	5.83e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTP1—coronary artery disease	2.41e-06	5.82e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—VCAN—coronary artery disease	2.4e-06	5.81e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CAT—coronary artery disease	2.4e-06	5.8e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.39e-06	5.77e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOA1—coronary artery disease	2.39e-06	5.77e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.38e-06	5.76e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK1—coronary artery disease	2.38e-06	5.76e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HMOX1—coronary artery disease	2.38e-06	5.74e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CD36—coronary artery disease	2.36e-06	5.69e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CAT—coronary artery disease	2.34e-06	5.67e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOB—coronary artery disease	2.33e-06	5.63e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPP2CA—coronary artery disease	2.33e-06	5.62e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—DCN—coronary artery disease	2.31e-06	5.59e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS2—coronary artery disease	2.29e-06	5.53e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOB—coronary artery disease	2.28e-06	5.5e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTM1—coronary artery disease	2.27e-06	5.48e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.25e-06	5.44e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MTHFR—coronary artery disease	2.23e-06	5.4e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—LPL—coronary artery disease	2.23e-06	5.38e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTM1—coronary artery disease	2.21e-06	5.35e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HBA1—coronary artery disease	2.19e-06	5.3e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LIPC—coronary artery disease	2.19e-06	5.3e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.19e-06	5.3e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.19e-06	5.3e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOC3—coronary artery disease	2.18e-06	5.27e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—LPL—coronary artery disease	2.17e-06	5.25e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GPX1—coronary artery disease	2.17e-06	5.25e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LDLR—coronary artery disease	2.17e-06	5.24e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CA—coronary artery disease	2.16e-06	5.22e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.14e-06	5.17e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.14e-06	5.17e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AGT—coronary artery disease	2.12e-06	5.13e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GPX1—coronary artery disease	2.12e-06	5.12e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GCLC—coronary artery disease	2.12e-06	5.12e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CETP—coronary artery disease	2.12e-06	5.12e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CD36—coronary artery disease	2.12e-06	5.11e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARG—coronary artery disease	2.1e-06	5.08e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SDC1—coronary artery disease	2.09e-06	5.06e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPP2CA—coronary artery disease	2.09e-06	5.05e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOE—coronary artery disease	2.08e-06	5.02e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—POMC—coronary artery disease	2.07e-06	5.01e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CA—coronary artery disease	2.07e-06	5e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CD36—coronary artery disease	2.06e-06	4.99e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOA1—coronary artery disease	2.05e-06	4.97e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.04e-06	4.93e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MTHFR—coronary artery disease	2e-06	4.84e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.98e-06	4.78e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.98e-06	4.78e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.97e-06	4.76e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MTHFR—coronary artery disease	1.96e-06	4.73e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CTGF—coronary artery disease	1.93e-06	4.67e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.91e-06	4.63e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GOT2—coronary artery disease	1.91e-06	4.63e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AGT—coronary artery disease	1.9e-06	4.6e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ALB—coronary artery disease	1.89e-06	4.57e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOE—coronary artery disease	1.87e-06	4.51e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AGT—coronary artery disease	1.86e-06	4.49e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOA1—coronary artery disease	1.84e-06	4.46e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6—coronary artery disease	1.83e-06	4.42e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOE—coronary artery disease	1.82e-06	4.4e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARG—coronary artery disease	1.81e-06	4.38e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NOS3—coronary artery disease	1.81e-06	4.37e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOA1—coronary artery disease	1.8e-06	4.35e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—POMC—coronary artery disease	1.79e-06	4.32e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.77e-06	4.27e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—AKT1—coronary artery disease	1.77e-06	4.27e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.76e-06	4.25e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.71e-06	4.12e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—AKT1—coronary artery disease	1.69e-06	4.08e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.65e-06	4e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GGT1—coronary artery disease	1.65e-06	3.99e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GOT1—coronary artery disease	1.65e-06	3.99e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARG—coronary artery disease	1.63e-06	3.93e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—POMC—coronary artery disease	1.6e-06	3.87e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARG—coronary artery disease	1.59e-06	3.83e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—POMC—coronary artery disease	1.56e-06	3.78e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NOS3—coronary artery disease	1.56e-06	3.76e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.48e-06	3.59e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.47e-06	3.55e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.46e-06	3.54e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALB—coronary artery disease	1.46e-06	3.53e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CAT—coronary artery disease	1.44e-06	3.49e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALB—coronary artery disease	1.43e-06	3.45e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS2—coronary artery disease	1.42e-06	3.44e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CA—coronary artery disease	1.41e-06	3.4e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOB—coronary artery disease	1.4e-06	3.39e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NOS3—coronary artery disease	1.4e-06	3.38e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NOS3—coronary artery disease	1.36e-06	3.3e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.36e-06	3.3e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LPL—coronary artery disease	1.34e-06	3.24e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPX1—coronary artery disease	1.31e-06	3.16e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.28e-06	3.09e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CD36—coronary artery disease	1.27e-06	3.07e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.26e-06	3.04e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS2—coronary artery disease	1.25e-06	3.02e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.21e-06	2.91e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AKT1—coronary artery disease	1.15e-06	2.78e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AGT—coronary artery disease	1.15e-06	2.77e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOE—coronary artery disease	1.12e-06	2.71e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOA1—coronary artery disease	1.11e-06	2.68e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.02e-06	2.46e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARG—coronary artery disease	9.77e-07	2.36e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—POMC—coronary artery disease	9.64e-07	2.33e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALB—coronary artery disease	8.79e-07	2.12e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CA—coronary artery disease	8.76e-07	2.12e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NOS3—coronary artery disease	8.41e-07	2.03e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AKT1—coronary artery disease	8.31e-07	2.01e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CA—coronary artery disease	7.87e-07	1.9e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS2—coronary artery disease	7.69e-07	1.86e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CA—coronary artery disease	7.68e-07	1.86e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AKT1—coronary artery disease	7.16e-07	1.73e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AKT1—coronary artery disease	6.43e-07	1.55e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AKT1—coronary artery disease	6.27e-07	1.52e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.73e-07	1.14e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AKT1—coronary artery disease	3.86e-07	9.34e-06	CbGpPWpGaD
